The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

Recent Progress on Antifungal Drug Development

(2011) Bing Zhai et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole

(2011) M. Spitzer et al.   Molecular Systems Biology

The Antidepressant Sertraline Inhibits Translation Initiation by Curtailing Mammalian Target of Rapamycin Signaling

(2010) C. J. Lin et al.   CANCER RESEARCH

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

The Antidepressant Sertraline Targets Intracellular Vesiculogenic Membranes in Yeast

(2010) M. M. Rainey et al.   GENETICS

Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect

(2010) B. Zhai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Amphotericin B: side effects and toxicity

(2009) Rafael Laniado-Laborín et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Diagnosis and therapy of fungal infection in patients with leukemia—new drugs and immunotherapy

(2008) Elias J. Anaissie   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani

(2008) P. Palit et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model

(2007) Qi Peng et al.   EXPERIMENTAL NEUROLOGY